Cefepime vs. Piperacillin-Tazobactam for Infection?  The ACORN Trial

June 07, 2024 00:22:24
Cefepime vs. Piperacillin-Tazobactam for Infection?  The ACORN Trial
Critical Care Perspectives in Emergency Medicine
Cefepime vs. Piperacillin-Tazobactam for Infection?  The ACORN Trial

Jun 07 2024 | 00:22:24

/

Show Notes

Timely and appropriate administration of empiric broad-spectrum antibiotics for adult patients with sepsis is critical.  Current guidelines recommend an antipseudomonal antibiotic for those at risk of a resistant gram-negative organism.  The two most common antipseudomonal antibiotics prescribed in this setting are cefepime and piperacillin-tazobactam.  In recent years, observational studies have reported an association with cefepime and neurotoxicity, whereas piperacillin-tazobactam has been associated with AKI especially when given with vancomycin.  In this podcast, we discuss the recently published ACORN Trial, a randomized trial that evaluated cefepime and piperacillin-tazobactam for adult patients with suspected infection.

Other Episodes

Episode 0

January 29, 2019 00:30:02
Episode Cover

ECLS in the ED

Extracorporeal life support (ECLS) is being used with increasing frequency in many EDs across the US and across the World. In this podcast, we...

Listen

Episode 0

March 17, 2024 00:22:04
Episode Cover

Steroids in Sepsis, ARDS, and CAP - A Focused Clinical Update

Critically ill patients commonly develop a dysregulated inflammatory response. Corticosteroids are hypothesized to be beneficial due to their anti-inflammatory properties.  In recent years, several...

Listen

Episode 0

October 26, 2021 00:26:40
Episode Cover

Vasopressin and Steroids for IHCA?

In 2009 and 2013 investigators published studies that demonstrated improved outcomes in patients with IHCA who received vasopressin and steroids in addition to epinephrine. ...

Listen